Brand names: Lopid
A lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol. These decreases occur primarily in the VLDL fraction and less frequently in the LDL fraction. Gemfibrozil increases HDL subfractions HDL2 and HDL3 as well as apolipoproteins A-I and A-II. Its mechanism of action has not been definitely established.
This tool is for educational purposes only. It is NOT
intended for diagnostic purposes. Only a physician or
licensed provider may diagnose and treat diseases. Read the
Terms and Conditions and
What is Symcat?
A disease calculator that uses hundreds of thousands of
patient records to estimate probability of disease. You
may have heard of Watson by IBM, which illustrates a trend of
computing and predictive analytics in
healthcare. We strive to empower people and medical professionals
by placing the state-of-the-art in
computer diagnosis at their fingertips. read more...